Business, energy, technology, markets and global industry news from Business News Today

Joseph C. Wu

PharmaDeviceNews Joseph C. Wu
Patient-derived pancreatic islet organoids and multi-omics research illustrate Greenstone Biosciences’ Breakthrough T1D-backed effort to study beta-cell vulnerability in type 1 diabetes. Representative image.
Pharma & Biotech

Can Greenstone’s patient-derived islet organoids reveal why some beta cells fail first in type 1 diabetes?

Greenstone Biosciences will build patient-derived islet organoids to study beta-cell vulnerability and identify potential type 1 diabetes drug targets.

Read More
Greenstone Biosciences is advancing patient-derived cardiac cell research to identify potential therapies targeting cardiac fibrosis and cardiomyopathy in Duchenne muscular dystrophy following an NIH R61 grant. Representative image.
Pharma & Biotech

Can Greenstone Biosciences turn patient-derived heart cells into a Duchenne cardiomyopathy drug?

Greenstone Biosciences secured an NIH R61 grant to discover cardiac fibrosis drugs for Duchenne muscular dystrophy using iPSC and AI models.

Read More